fda compounding semaglutide update As of February 21, 2025, the updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A SEMAGLUTIDE 15 MONTH UPDATE |

These effects are magnified in Utahs dry climate, which accelerates skin thinning and moisture loss, making volume loss more visible. In fact, new research suggests that GLP-1 drugs may alter how stem cells function, reducing their ability to create fibroblasts and pre-adipocytesboth essential for producing collagen and elastin

International purchasing adds complexity

More fat lost

Patients who stop GLP-1 therapy often regain weight within months, but steady access removes the financial friction that causes treatment gaps

The 6.6 percentage-point gain from adding cagrilintide to semaglutide is the cleanest existing read on what amylin layering buys you on top of an incretin agonist

Effects of liraglutide on expressions of lipid metabolism-related genes in rats with T2DM and fatty liver